Blake Byers
Co-founder of NewLimit & investor in tech and biotech companies
Blake Byers is a Co-founder of NewLimit. He was a General Partner at Google Ventures where he led investments in tech and biotech companies. Over a decade, Blake led early investments in tech companies including Robinhood, Gusto, Dapper, Blockchain.com, and IonQ, and biotech companies including Denali, Forty Seven, Magenta, Arcus, Armo, Grail, Freenome, and many others. Blake previously incubated PACT Pharma where he was founding president and now serves as Chairman of the board.
Blake received a PhD and MS in bioengineering from Stanford University and holds a BS in biomedical engineering and BS in economics from Duke University.
Visit website: https://www.newlimit.com/about#BlakeByers
See also: NewLimit - Company focused on human health and Rejuvenation
Details last updated 19-Dec-2021
Blake Byers News
TechCrunch interviews founders of NewLimit after it received another $40m of funding
TechCrunch - 16-May-2023
Reprogramming the epigenetics of a cell could reverse a significant amount of the functional decline that we see with age
Read more...NewLimit, a new biotech launches to slowdown or reverse ageing
NewLimit - 12-Dec-2021
Aims to extend healthspan and cure ageing with affordable epigenetic therapies
Read more...